JP2010520917A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520917A5
JP2010520917A5 JP2009553146A JP2009553146A JP2010520917A5 JP 2010520917 A5 JP2010520917 A5 JP 2010520917A5 JP 2009553146 A JP2009553146 A JP 2009553146A JP 2009553146 A JP2009553146 A JP 2009553146A JP 2010520917 A5 JP2010520917 A5 JP 2010520917A5
Authority
JP
Japan
Prior art keywords
azepino
tetrahydro
indole
sulfonyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009553146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520917A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/053002 external-priority patent/WO2008110598A1/en
Publication of JP2010520917A publication Critical patent/JP2010520917A/ja
Publication of JP2010520917A5 publication Critical patent/JP2010520917A5/ja
Withdrawn legal-status Critical Current

Links

JP2009553146A 2007-03-13 2008-03-13 肥満治療用三環式イソキノリン誘導体 Withdrawn JP2010520917A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0700611 2007-03-13
US202907P 2007-11-05 2007-11-05
PCT/EP2008/053002 WO2008110598A1 (en) 2007-03-13 2008-03-13 Tricyclic isoquinoline derivatives for treatment of obesity

Publications (2)

Publication Number Publication Date
JP2010520917A JP2010520917A (ja) 2010-06-17
JP2010520917A5 true JP2010520917A5 (cg-RX-API-DMAC7.html) 2011-05-06

Family

ID=39462457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009553146A Withdrawn JP2010520917A (ja) 2007-03-13 2008-03-13 肥満治療用三環式イソキノリン誘導体

Country Status (10)

Country Link
US (1) US8138333B2 (cg-RX-API-DMAC7.html)
EP (1) EP2134714A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010520917A (cg-RX-API-DMAC7.html)
CN (1) CN101631787A (cg-RX-API-DMAC7.html)
AU (1) AU2008225753A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0808791A2 (cg-RX-API-DMAC7.html)
CA (1) CA2679346A1 (cg-RX-API-DMAC7.html)
EA (1) EA016592B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ579360A (cg-RX-API-DMAC7.html)
WO (1) WO2008110598A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101653707B1 (ko) * 2008-05-29 2016-09-02 알바니 몰레큘라 리써치, 인크. 5-ht3 수용체 조절제, 이의 제조 방법, 및 그의 용도
WO2011153359A1 (en) 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
WO2012106448A1 (en) * 2011-02-02 2012-08-09 Biocryst Pharmaceuticals, Inc. Heterocyclic compounds as janus kinase inhibitors
EP2824106B1 (en) * 2012-03-06 2016-11-23 Takeda Pharmaceutical Company Limited Tricyclic compound
US10675283B2 (en) 2017-03-24 2020-06-09 University Of South Florida Compositions and methods for white to beige adipogenesis
CN109180687A (zh) * 2018-08-31 2019-01-11 山东轩德医药科技有限公司 一种瑞卡帕步中间体的制备方法
CN111961047A (zh) * 2020-08-19 2020-11-20 南通大学 一种6-乙氧基-3,4-二氢-2,7-萘啶-1(2h)-酮及其合成方法
CN115925658B (zh) * 2022-11-21 2024-02-27 常州佳德医药科技有限公司 一种2-氨基乙基呋喃的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
CA2194984C (en) 1994-07-26 2002-07-02 John Eugene Macor 4-indole derivatives as serotonin agonists and antagonists
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
GB9820113D0 (en) 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
AU767009B2 (en) 1998-12-11 2003-10-30 Virginia Commonwealth University Selective 5-HT6 receptor ligands
KR100823908B1 (ko) 2000-10-20 2008-04-21 바이오비트럼 에이비(피유비엘) 2-, 3-, 4-, 또는 5-치환-n1-(벤젠술포닐)인돌 및 이의치료 용도
JP4390698B2 (ja) * 2002-06-05 2009-12-24 エフ.ホフマン−ラ ロシュ アーゲー Cns障害の処置のための5−ht6レセプターモジュレーターとしての1−スルホニル−4−アミノアルコキシインドール誘導体

Similar Documents

Publication Publication Date Title
RU2485114C2 (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов
AU2005215918C1 (en) Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
JP5456891B2 (ja) Cyp17阻害剤としての1,3−二置換イミダゾリジン−2−オン誘導体
KR101730681B1 (ko) C형 간염 바이러스 억제제
WO2020210828A1 (en) (aza)indazolyl-aryl sulfonamide and related compounds and their use in treating medical conditions
RU2223116C2 (ru) Применение производных арил (или гетероарил) азолилкарбинолов в приготовлении лекарственного средства для лечения нарушений, опосредованных избытком вещества p
JP2006521343A5 (cg-RX-API-DMAC7.html)
AU2017265027A1 (en) Heterocyclic modulators of lipid synthesis
CA2602248A1 (en) Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
JP2012528166A5 (cg-RX-API-DMAC7.html)
JP2012532931A5 (cg-RX-API-DMAC7.html)
AU2006284077B2 (en) Use of azabicyclo hexane derivatives
JP2017505762A5 (cg-RX-API-DMAC7.html)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
TW200922932A (en) Heterocyclic compound and pharmaceutical composition thereof
RU2009146851A (ru) Гетероарил-замещенные пиразольные производные, которые могут использоваться для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом
JP2012525431A5 (cg-RX-API-DMAC7.html)
JP2012525332A5 (cg-RX-API-DMAC7.html)
KR20020038959A (ko) 티로신 키나제 억제제
IL295076B2 (en) Piperidinone derivatives as MDM2 inhibitors for cancer treatment
JP2006514011A5 (cg-RX-API-DMAC7.html)
JP2019519586A5 (cg-RX-API-DMAC7.html)
JP2012502006A5 (cg-RX-API-DMAC7.html)
CA2564629C (en) Substituted phenylaminopyrimidines
JP2013532709A5 (cg-RX-API-DMAC7.html)